Serum Institute
HEXASIIL PFS
₹ 2,690 / Piece
No Charges till Medical Approval
Hexasil Vaccine
Hexasil is a combination vaccine that protects against six serious diseases: diphtheria, tetanus, whooping cough (w-pertussis), hepatitis B, polio, and Haemophilus influenzae type b (Hib). It simplifies pediatric immunization by reducing the number of injections while ensuring comprehensive protection.
Key Benefits:
- Provides long-term immunity against six diseases
- Fewer injections, making vaccination easier for infants
- Clinically proven with high seroprotection rates
Dosage & Administration:
- Primary series: 3 doses starting at 6 weeks (at 6, 10, and 14 weeks)
- Booster dose: Given 6+ months after the last primary dose (12–15 or 12–23 months)
- Administration: Intramuscular injection in the upper thigh
Safety & Side Effects:
💉 Common side effects: mild fever, pain at the injection site, irritability
⚠ Severe reactions are rare
Who Should Not Take It?
- Individuals with severe allergies to vaccine components
- Infants with acute illness or history of febrile convulsions
Minimum Age: 6 weeks
Maximum Age: 2 years
- COD Available
- Genuine Quality
Delivery Options
Get delivery at your doorstep
Prescription Compulsory
| Imported | No |
| Doses | 4 |
| Antigens | 6 |
| Vaccine Type | Painful |
| Pregnancy | No |
| Lactation | No |
| Boosters | 1 |
| ACVIP 2020 Guidelines | Yes |
| > 6 wk- 2 yr | Yes |
| Adult vaccine | No |
Hexasil Vaccine
Hexasil is a combination vaccine that provides protection against six serious diseases: diphtheria, tetanus, w-pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and Haemophilus influenzae type b (Hib). This vaccine is commonly used in pediatric immunization programs to ensure comprehensive protection with fewer injections.
How It Works
Hexasil contains inactivated components of the bacteria and viruses that cause these diseases, stimulating the immune system to develop immunity without causing the actual diseases.
Administration
- Primary Series: Given as a series of three injections starting at 6 weeks of age, with a minimum interval of 1 month (4 weeks) between each dose.
- WHO Recommendation: 6, 10, and 14 weeks as the primary schedule. Interval can vary between 4–8 weeks between doses.
- Booster Dose: Administered at least 6 months after the last primary dose, typically between 12–15 months or 12–23 months of age.
- Alternate Schedule: If hepatitis B is administered at birth, the primary schedule remains at 6, 10, and 14 weeks.
- Route: Administered intramuscularly, usually in the upper thigh for infants (alternating thighs).
Side Effects
- Pain or swelling at the injection site
- Fever
- Irritability
- Loss of appetite
- Fatigue
⚠ Note: Severe reactions are rare.
Pregnancy and Lactation
- Pregnancy: Not applicable, as it is intended for infants and young children.
- Lactation: Not applicable. Safe for nursing mothers to administer to their infants.
Efficacy Studies
Long-Term Protection: Studies have shown that Hexasil provides long-lasting protection against all six diseases, with close to 100% seroprotection observed by 9 years of age.
Age Group
- Minimum Age: Approved for use in infants starting at 6 weeks old.
- Maximum Age: Recommended for children up to 2 years old.
Contraindications
- Allergic Reactions: Not for individuals with severe allergies to any component of the vaccine.
- Severe Illness: Vaccination should be postponed in cases of acute, severe febrile illness or history of febrile convulsions.
Review and Ratings
No Customer Reviews
Share your thoughts with other customers
